Epinephrine Auto-Injectors Market

Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure. This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.

Epinephrine Auto-Injectors Market contains market size and forecasts of Epinephrine Auto-Injectors in global, including the following market information:

• Global Epinephrine Auto-Injectors Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Epinephrine Auto-Injectors Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Epinephrine Auto-Injectors companies in 2021 (%)

The global Epinephrine Auto-Injectors market was valued at 1284.7 million in 2021 and is projected to reach US$ 1799.1 million by 2028, at a CAGR of 4.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

0.3 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Epinephrine Auto-Injectors include Viatris, Teva Pharmaceutica, ALK Abello, Amneal Pharmaceuticals, Kalo, Bioprojet Pharma, Bausch Health and Novartis Sandoz, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Epinephrine Auto-Injectors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Epinephrine Auto-Injectors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Epinephrine Auto-Injectors Market Segment Percentages, by Type, 2021 (%)

• 0.3 mg
• 0.15 mg
• 0.5 mg
• 0.1 mg

Global Epinephrine Auto-Injectors Market, by End User, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Epinephrine Auto-Injectors Market Segment Percentages, by End User, 2021 (%)

• Under 6 Years Patients
• 6 to 12 Years Patients
• Over 12 Years Patients

Global Epinephrine Auto-Injectors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Epinephrine Auto-Injectors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Epinephrine Auto-Injectors revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Epinephrine Auto-Injectors revenues share in global market, 2021 (%)
• Key companies Epinephrine Auto-Injectors sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Epinephrine Auto-Injectors sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Viatris
• Teva Pharmaceutica
• ALK Abello
• Amneal Pharmaceuticals
• Kalo
• Bioprojet Pharma
• Bausch Health
• Novartis Sandoz